Skip to main content
VALIRX PLC logo

VALIRX PLC — Investor Relations & Filings

Ticker · VAL ISIN · GB00BLH13C52 LEI · 213800VQKB9SJCQDET40 IL Professional, scientific and technical activities
Open in API
Filings indexed 574 across all filing types
Latest filing 2023-03-01 Regulatory Filings
Country GB United Kingdom
Listing IL VAL

About VALIRX PLC

https://www.valirx.com/

ValiRx PLC is a life science company that accelerates the development of therapeutics and diagnostics, with a primary focus on oncology and women's health. The company's business model centers on identifying and progressing promising early-stage scientific discoveries through pre-clinical and clinical development. ValiRx provides scientific, financial, and commercial expertise to translate novel research into clinically validated treatments, aiming to improve patient outcomes in its target therapeutic areas.

Recent filings

Filing Released Lang Actions
Incorporation of Inaphaea BioLabs Limited
Regulatory Filings Classification · 1% confidence The document begins with 'RNS Number : 4168R' and concludes with boilerplate text referencing 'RNS, the news service of the London Stock Exchange' and the FCA. This strongly indicates a regulatory news service announcement. The content details the incorporation of a new subsidiary, Inaphaea BioLabs Limited, and outlines its business strategy (a translational Contract Research Organisation or tCRO). This type of corporate action announcement, which is not a full financial report (10-K, IR), earnings release (ER), or a specific transaction report (DIV, DIRS, POS), fits best under the general regulatory announcement category, RNS, as it is a material operational update disseminated via the official news service.
2023-03-01 English
Second Price Monitoring Extn
Regulatory Filings Classification · 1% confidence The document is very short (1928 chars) and contains the header 'RNS Number : 0446R'. It announces a 'Second Price Monitoring Extension' related to trading activity, which is a specific operational announcement. It explicitly states that the information is provided by RNS, the news service of the London Stock Exchange, and is approved by the FCA as a Primary Information Provider. This type of specific, non-financial report announcement that originates from the exchange's news service fits best under the general Regulatory Filings category (RNS), as there is no more specific category for price monitoring extensions or trading halts/extensions. It is not a report itself, but a regulatory notification.
2023-02-24 English
Price Monitoring Extension
Regulatory Filings Classification · 1% confidence The document explicitly starts with 'RNS Number' and mentions 'RNS, the news service of the London Stock Exchange' multiple times. The content describes a 'Price Monitoring Extension' for a security, which is a specific type of market operational announcement. Since this is a general regulatory announcement disseminated via the RNS system and does not fit into the more specific categories like 10-K, ER, or DIV, it falls best under the general 'Regulatory Filings' category, which serves as the fallback for miscellaneous regulatory announcements not covered elsewhere. The document length is short (1911 chars), but it is the primary announcement itself, not an announcement *of* another report.
2023-02-24 English
Result of GM, Issue of Equity
AGM Information Classification · 1% confidence The document is an official announcement disseminated via RNS (RNS Number: 7721O) from ValiRx PLC. The content details the 'Result of GM' (General Meeting) where resolutions were passed, followed by an 'Issue of Equity' (issuance of new ordinary shares and warrants) related to a prior fundraising announcement. It also mentions the expected 'Admission' of these new shares to trading on AIM and updates the 'Total voting rights'. This type of broad, time-sensitive corporate update, especially one originating from the London Stock Exchange's RNS system, fits best under the general regulatory announcement category. Since it is not a full financial report (10-K, IR), a specific management/board change (MANG), or a specific voting result declaration (DVA), the most appropriate classification is the general regulatory filing fallback.
2023-02-02 English
Operational Update
Regulatory Filings Classification · 1% confidence The document is identified by the header 'RNS Number : 3257O' and concludes with information about 'RNS, the news service of the London Stock Exchange' and the FCA. This strongly indicates a regulatory announcement made via the London Stock Exchange's Regulatory News Service (RNS). The content details an 'Operational Update' including signing a laboratory lease and confirming a permanent appointment for the CSO. This type of material announcement, which is not a comprehensive financial report (like 10-K or IR) or a specific shareholder vote result, fits best into the general regulatory announcement category, which is RNS.
2023-01-31 English
Holding(s) in Company
Major Shareholding Notification Classification · 1% confidence The document is explicitly labeled with an 'RNS Number' and contains the header 'TR-1: Standard form for notification of major holdings'. This form is used to report changes in significant share ownership (crossing thresholds) by individuals or entities, which falls under regulatory disclosure requirements. Specifically, Section 7 details the 'Resulting situation' of voting rights held by 'nicholas slater'. This type of filing, reporting insider or major shareholder transactions/holdings, is best classified under Major Shareholding Notification (MRQ) or, given the context of being an RNS announcement from the London Stock Exchange, it could also fit the general Regulatory Filings (RNS) category. However, since 'MRQ' specifically covers 'Notification of changes in significant share ownership levels (crossing thresholds)', it is the most precise fit for a TR-1 form.
2023-01-31 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.